Molecular mechanisms and timing of cortical immune activation in schizophrenia.

Hyde TM, Bharadwaj RA. Molecular mechanisms and timing of cortical immune activation in schizophrenia. Am J Psychiatry. 2015;172(11):1052-3. DOI: 10.1176/appi.ajp.2015.15091187. PubMed PMID: 26575443.

CHRNA7 and CHRFAM7A: psychosis and smoking? Blame the neighbors!

Akbarian S, Kundakovic M. CHRNA7 and CHRFAM7A: psychosis and smoking? Blame the neighbors!. Am J Psychiatry. 2015;172(11):1054-6. DOI: 10.1176/appi.ajp.2015.15081018. PubMed PMID: 26575444.

Circulating miRNA biomarkers for schizophrenia?

Cairns MJ. Circulating miRNA biomarkers for schizophrenia?. Am J Psychiatry. 2015;172(11):1059-61. DOI: 10.1176/appi.ajp.2015.15081060. PubMed PMID: 26575446.

Imaging the "GABA shift" in schizophrenia.

Abi-Dargham A. Imaging the "GABA shift" in schizophrenia. Am J Psychiatry. 2015;172(11):1062-3. DOI: 10.1176/appi.ajp.2015.15081088. PubMed PMID: 26575447.

Concerns over your recent paper on risperidone long-acting injectable for treatment-resistant schizophrenia.

Kanaan RA. Concerns over your recent paper on risperidone long-acting injectable for treatment-resistant schizophrenia. Schizophr Res. 2015;169(1-3):506. DOI: 10.1016/j.schres.2015.10.009. PubMed PMID: 26560037.

Physical activity and sedentary behavior measured objectively and subjectively in overweight and obese adults with schizophrenia or schizoaffective disorders.

Janney CA, Ganguli R, Tang G, Cauley JA, Holleman RG, Richardson CR, et al. Physical activity and sedentary behavior measured objectively and subjectively in overweight and obese adults with schizophrenia or schizoaffective disorders. J Clin Psychiatry. 2015;76(10):e1277-84. DOI: 10.4088/JCP.14m09330. PubMed PMID: 26528650.

Do advanced statistical techniques really help in the diagnosis of the metabolic syndrome in patients treated with second-generation antipsychotics?

Van Schependom J, Yu W, Gielen J, Laton J, De Keyser J, De Hert M, et al. Do advanced statistical techniques really help in the diagnosis of the metabolic syndrome in patients treated with second-generation antipsychotics?. J Clin Psychiatry. 2015;76(10):e1292-9. DOI: 10.4088/JCP.14m09367. PubMed PMID: 26528652.

How to best treat patients with schizophrenia and co-occurring alcohol use disorder.

Petrakis IL. How to best treat patients with schizophrenia and co-occurring alcohol use disorder. J Clin Psychiatry. 2015;76(10):e1338-9. DOI: 10.4088/JCP.14com09625. PubMed PMID: 26528664.

What is the right pharmacotherapy for alcohol use disorder in patients with schizophrenia?

Batki SL. What is the right pharmacotherapy for alcohol use disorder in patients with schizophrenia?. J Clin Psychiatry. 2015;76(10):e1336-7. DOI: 10.4088/JCP.14com09611. PubMed PMID: 26528663.

Treatment-resistant schizophrenic patients respond to clozapine after olanzapine non-response.

Conley RR, Tamminga CA, Kelly DL, Richardson CM. Treatment-resistant schizophrenic patients respond to clozapine after olanzapine non-response. Biol Psychiatry. 1999;46(1):73-7. PubMed PMID: 10394475.